Trial Profile
Effect of Piperacillin/Tazobactam on hematological parameters in patients with Moderate or Severe Foot Infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2018
Price :
$35
*
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Diabetic foot
- Focus Adverse reactions
- 20 Feb 2018 New trial record
- 01 Feb 2018 Results published in the Diabetes Therapy